These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. Kirby WM; De Maine JB; Serrill WS Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. Fillastre JP; Leroy A; Godin M; Oksenhendler G; Humbert G J Antimicrob Chemother; 1978 Jul; 4(B):79-83. PubMed ID: 690027 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients. Leroy A; Canonne MA; Fillastre JP; Humbert G Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics of ceftazidime in normal and impaired renal function. Höffler D; Koeppe P; Williams KJ Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of ceftazidime in normal and impaired renal function. Höffler D; Koeppe P; Williams KJ J Antimicrob Chemother; 1983 Jul; 12 Suppl A():241-5. PubMed ID: 6352626 [TBL] [Abstract][Full Text] [Related]
10. Ceftazidime: pharmacokinetics in patients and effects on the renal function. Norrby SR; Burman LA; Linderholm H; Trollfors B J Antimicrob Chemother; 1982 Sep; 10(3):199-206. PubMed ID: 6754681 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics of cefazolin in normal and uremic subjects. Welling PG; Craig WA; Gordon AL; Kunin CM Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients. Craig CP; Rifkin SI Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftazidime in premature, newborn and young infants. Prinsloo JG; Delport SD; Moncrieff J; Paton AM S Afr Med J; 1984 May; 65(20):809-11. PubMed ID: 6374925 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. Andriole VT J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis. Tourkantonis A; Nicolaidis P J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629 [TBL] [Abstract][Full Text] [Related]
17. A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants. Prinsloo JG; Delport SD; Moncrieff J; Paton AM J Antimicrob Chemother; 1983 Jul; 12 Suppl A():361-4. PubMed ID: 6352645 [TBL] [Abstract][Full Text] [Related]
18. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency. van Dalen R; Vree TB; Hafkenscheid JC; Gimbrère JS J Antimicrob Chemother; 1979 May; 5(3):281-92. PubMed ID: 479064 [No Abstract] [Full Text] [Related]
19. Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections. Naber KG; Kees F; Grobecker H J Antimicrob Chemother; 1983 Jul; 12 Suppl A():41-5. PubMed ID: 6352653 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of furosemide in advanced renal failure. Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027 [No Abstract] [Full Text] [Related] [Next] [New Search]